Transaction summary
- Target
- GW Pharmaceuticals
- Acquirer
- Jazz Pharmaceuticals
- Seller
- -
- Announced
- 2021-02-03
- Completed
- 2021-05-05
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-10-21
Value and multiples
100% enterprise value
USD 7.2B
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
12.9x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- CNBC reported a USD 7.2bn deal, and Jazz Pharmaceuticals completed the acquisition on 5 May 2021. The 12.9x EBITDA multiple comes from FundComb’s comps spreadsheet and is not confirmed by a public source; the EBITDA amount, period and basis behind it are not stated.
Source summary
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc - PR Newswire
ConfirmedContinue your research
Related transaction comps
Biotech
ITM Isotope Technologies Munich SE acquired by Telix Pharmaceuticals Limited
2026-09-20 · Confirmed
View transaction → BiotechDersimelagon rights acquired by LEO Pharma
2026-08-18 · Confirmed
View transaction → BiotechEdgewise Therapeutics' Muscular Dystrophy Business acquired by Servier
2026-07-13 · Confirmed
View transaction → Biotech4E Therapeutics acquired by Eli Lilly and Company
2026-06-16 · Confirmed
View transaction →